MBX
MBX Biosciences, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.52B
P/E Ratio
—
EPS
$-2.17
Beta
—
52W High
$45.85
52W Low
$9.43
50-Day MA
$31.62
200-Day MA
$26.77
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About MBX Biosciences, Inc. Common Stock
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. The company is headquartered in Carmel, Indiana.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-98.56M |
| Operating Margin | 0.00% |
| Return on Equity | -25.70% |
| Return on Assets | -17.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $9.20 |
| Price-to-Book | 3.46 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $47.60M |
| Float | $29.61M |
| % Insiders | 2.70% |
| % Institutions | 111.47% |
Historical Volatility
HV 10-Day
65.73%
HV 20-Day
99.57%
HV 30-Day
83.69%
HV 60-Day
78.34%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($69.09 target)
2
Strong Buy9
Buy1
SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026